Table 3

Sociodemographic profile of attenders and non-attenders in the IDEAS trial

IDEAS participants (invited) (n=1051)Trial non-attenders(n=990)Trial attenders (n=61)
Total (n=61)Control (n=34)Incentive (n=27)
Total (n=27)Fixed (n=17)Lottery (n=10)
Gender
 Male, n (%)609 (57.9)577 (58.3)32 (52.5)20 (58.8)12 (44.4)9 (52.9)3 (30.0)
 Female, n (%)442 (42.1)413 (41.7)29 (47.5)14 (41.2)15 (55.6)8 (47.1)7 (70.0)
p=0.371Non-attenders versus attendersp=0.264Incentive versus control
Age (years)
 ≤65, n (%)578 (55.0)541 (54.6)37 (60.7)19 (55.9)18 (66.7)10 (58.8)8 (80.0)
 >65, n (%)473 (45.0)449 (45.4)24 (39.3)15 (44.1)9 (33.3)7 (41.2)2 (20.0)
p=0.360Non-attenders versus attendersp=0.392Incentive versus control
IMD decile
 0–20, n (%)556 (52.9)522 (52.7)34 (55.7)19 (55.9)15 (55.5)10 (58.8)5 (50.0)
 30–60, n (%)495 (47.1)468 (47.3)27 (44.3)15 (44.1)12 (44.4)7 (41.2)5 (50.0)
p=0.648Non-attenders versus attendersp=0.980Incentive versus control
Distance from clinic (km)
 Mean (SD) median range2.7 (1.81)2.50.0–17.52.71 (1.80)2.50.0–17.52.53 (1.94)2.00.5–10.02.94 (2.25)2.50.5–10.02.0 (1.32)2.00.5–6.52.09 (1.47)1.50.5–6.51.85 (1.06)2.00.5–3.5
p=0.447;IMD=−0.1895% CI (−0.65 to 0.29)Non-attenders versus attendersp=0.059;IMD=0.9495% CI (−0.04 to 1.92)Incentive versus control
Years registered
 Mean (SD) median range5.96 (2.17)7.02–85.96 (2.19)7.02–85.84 (1.95)6.02–85.79 (1.92)6.02–85.89 (2.03)6.02–85.65 (2.18)5.02–86.30 (1.77)6.53–8
p=0.654;IMD=−0.1395% CI (−0.69 to 0.43)Non-attenders versus attendersp=0.852;IMD=−0.9595% CI (−1.11 to 0.92)Incentive versus control
  • IDEAS, Incentives in Diabetic Eye Assessment by Screening; IMD, Indices of Multiple Deprivation.